ID Business Solutions (IDBS) today announced that Cancer Research Technology Ltd (CRT), a drug discovery company based in London wholly owned by the charity Cancer Research UK, will implement IDBS’ ActivityBase informatics platform to manage its chemical and biological drug discovery data. Working at the critical interface between academic research and the pharmaceutical industry, CRT’s role is to accelerate promising discoveries from the 200+ academic research projects funded by Cancer Research UK, into effective therapeutics in the clinic.
